Hardware Podcasts

#419: Essential Strategies for CRO Success in Today's Clinical Landscape

Global Medical Device Podcast · 11 Aug 2025 · 30m · Episode 419

What this episode covers

Christine Wilbert, an account executive at Greenlight Guru, discusses strategic considerations for Clinical Research Organizations (CROs) selecting Electronic Data Capture (EDC) systems. She emphasizes the critical need for due diligence, scalability from pilot to pivotal studies, and robust post-sales support to avoid hidden costs. The conversation highlights the importance of intuitive design, speed of implementation, and involving site users to ensure data integrity and adoption in medical device trials.

Most relevant to

established companies

Topics

Mentioned

Companies
Greenlight Guru
Tools
Microsoft Power BI
Also
FDA 21 CFR Part 11, ISO 14155, EU MDR

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 13m

    038 - "Clinical Trials" with Dan Sfera

    Dan Sfera, founder of Yuma Clinical Trials and author of the Comprehensive Guide to Clinical Research, explains the operational realities of clinical trials, highlighting the conflict between 'patient-centric' technology and actual patient burden. He details the high screen-failure rates in Phase 2 and 3 trials, the critical role of the Investigator's Form 1572, and the specific risks of investigational product mix-ups during randomization. Sfera also discusses the dynamics between sponsors, CROs, and sites, arguing that direct sponsor involvement often yields better outcomes than using rigid CROs.

    Validation & product-market fitQuality & yield
    10 chapters

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

    Validation & product-market fitManufacturing partners & offshoring
    8 chapters

  • Let's Combinate · 41m

    059 - Literature Review, EU MDR CER’s, and Being Problem Driven with Ethan Drower

    Ethan Drower, Co-Founder of CiteMed, explains how his company uses software to streamline the literature review process for EU MDR Clinical Evaluation Reports (CERs). He details the shift from ad-hoc searches to rigorous, reproducible protocols required by notified bodies, emphasizing the need to track search results and maintain continuous risk-benefit assessments. Drower discusses the operational challenges of managing large portfolios of devices and the importance of validating software tools to ensure compliance and efficiency in regulatory submissions.

    Certification & complianceValidation & product-market fit
    8 chapters

  • Let's Combinate · 28m

    054 - "EUDAMED" with Richard Houlihan

    Richard Houlihan, CEO of Eirmed, discusses the history, structure, and compliance requirements of EUDAMED, the European Commission's medical device database. He details the system's six modules, highlighting the complexity of the clinical investigations module and the shift from private competent authority access to public transparency for device data. Houlihan explains the legal obligations for economic operators, including manufacturers, authorized representatives, and importers, emphasizing that EUDAMED is a mandatory cost of doing business in Europe with strict data validation rules.

    Certification & complianceIntellectual property
    9 chapters

  • Let's Combinate · 1h 13m

    010 - "Don't Make Assumptions" with David Simoens

    David Simoens, COO of cGMP Consulting Group, explains how a risk-based approach can streamline commissioning, qualification, and validation (C&Q) in pharmaceutical manufacturing. He details the transition from traditional, repetitive testing to leveraging data from Factory Acceptance Tests (FAT) and Site Acceptance Tests (SAT) through rigorous User Requirement Specifications (URS) and risk assessments. Simoens highlights common pitfalls, such as poorly written 70-page URS documents and inadequate debugging at the vendor site, which lead to significant project delays and cost overruns. He emphasizes the importance of using tools like FMEA and ISPE guidelines to identify critical aspects early, ensuring that testing is performed once and leveraged through to Performance Qualification (PQ).

    Manufacturing partners & offshoringQuality & yield
    9 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.